| Dr Michael Alan Sherwin, DPM | |
|
234 36th St, Bellingham, WA 98225-6540 | |
| (360) 738-9797 | |
| (360) 738-9809 |
| Full Name | Dr Michael Alan Sherwin |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 37 Years |
| Location | 234 36th St, Bellingham, Washington |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487792966 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0131X | Podiatrist - Foot Surgery | PO00000490 (Washington) | Primary |
| Provider Name | Family Foot Care, P.s. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1609998004 PECOS PAC ID: 7719915990 Enrollment ID: O20050728001271 |
News Archive
Stemedica Cell Technologies, Inc. (Stemedica), a world leader in stem cell research and manufacturing, announced that it has filed an Investigative New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for a clinical trial. The trial will assess the safety, tolerability and efficacy of Stemedica's high potency proprietary allogeneic mesenchymal bone marrow-derived stem cells (adult human) as a treatment for ischemic stroke.
About three-quarters of women newly diagnosed with breast cancer have a friend or family member with them at their first visit with a surgeon. And that person plays a significant role in the patient's decision of what type of surgery to have, according to a new study from the University of Michigan Comprehensive Cancer Center.
Researchers from Italy have reported results from more than 10 years of follow-up showing that the placement of multiple endoscopic stents for the treatment of postoperative biliary strictures remains excellent with a low rate of stricture recurrence after this lengthy period of time. When strictures do recur, they can be safely and successfully retreated endoscopically. The study appears in the September issue of GIE: Gastrointestinal Endoscopy, the monthly peer-reviewed scientific journal of the American Society for Gastrointestinal Endoscopy (ASGE).
A nanoparticle-based drug delivery system that can sense and respond to different conditions in the body, as well as to an externally applied magnetic field, could enhance doctors' ability to target drugs to specific sites of disease.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Alan Sherwin, DPM 234 36th St, Bellingham, WA 98225-6540 Ph: (360) 738-9797 | Dr Michael Alan Sherwin, DPM 234 36th St, Bellingham, WA 98225-6540 Ph: (360) 738-9797 |
News Archive
Stemedica Cell Technologies, Inc. (Stemedica), a world leader in stem cell research and manufacturing, announced that it has filed an Investigative New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for a clinical trial. The trial will assess the safety, tolerability and efficacy of Stemedica's high potency proprietary allogeneic mesenchymal bone marrow-derived stem cells (adult human) as a treatment for ischemic stroke.
About three-quarters of women newly diagnosed with breast cancer have a friend or family member with them at their first visit with a surgeon. And that person plays a significant role in the patient's decision of what type of surgery to have, according to a new study from the University of Michigan Comprehensive Cancer Center.
Researchers from Italy have reported results from more than 10 years of follow-up showing that the placement of multiple endoscopic stents for the treatment of postoperative biliary strictures remains excellent with a low rate of stricture recurrence after this lengthy period of time. When strictures do recur, they can be safely and successfully retreated endoscopically. The study appears in the September issue of GIE: Gastrointestinal Endoscopy, the monthly peer-reviewed scientific journal of the American Society for Gastrointestinal Endoscopy (ASGE).
A nanoparticle-based drug delivery system that can sense and respond to different conditions in the body, as well as to an externally applied magnetic field, could enhance doctors' ability to target drugs to specific sites of disease.
› Verified 1 days ago
Geoffrey J Mcallister, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 520 Birchwood Ave Ste A, Bellingham, WA 98225 Phone: 360-734-3668 Fax: 360-676-8941 | |
Bellingham Foot Care Center, Inc Podiatrist Medicare: Medicare Enrolled Practice Location: 1600 F St, Bellingham, WA 98225 Phone: 360-733-3710 Fax: 360-733-7906 | |
Dr. Mark Whitman Sheafor, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3120 Squalicum Pkwy Ste 2, Bellingham, WA 98225 Phone: 360-647-0557 Fax: 360-733-2892 | |
Michael Czurylo, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2075 Barkley Blvd Ste 220, Bellingham, WA 98226 Phone: 360-933-4813 Fax: 360-933-4526 | |
Family Foot Care, P.s. Podiatrist Medicare: Medicare Enrolled Practice Location: 234 36th St, Bellingham, WA 98225 Phone: 360-738-9797 | |
Northwest Foot And Ankle Institute Pllc Podiatrist Medicare: Medicare Enrolled Practice Location: 2075 Barkley Blvd Ste 220, Bellingham, WA 98226 Phone: 224-688-9328 |